Francisco Fuster García

Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

Stefan Zeuzem, Graham R. Foster, Stanley Wang et al. · New England Journal of Medicine · 2018 · 437 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study

José Ignacio Vargas, José Ignacio Vargas, Daniela Jensen et al. · Vaccine · 2016 · 75 citations

Veterinary Medicine, Immunology, Infectious Diseases +15

Donor mannose-binding lectin gene polymorphisms influence the outcome of liver transplantation

Carlos Cervera, Domingo Balderramo, B. Suárez et al. · Liver Transplantation · 2009 · 50 citations

Life Sciences, Genetics, Molecular Genetics +15

Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV

José Ignacio Vargas, Daniela Jensen, Felipe Martínez et al. · JAMA Network Open · 2021 · 35 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Baveno VI and Expanded Baveno VI criteria successfully predicts the absence of high‐risk gastro‐oesophageal varices in a Chilean cohort

María Inés Gaete, Luis Antonio Díaz, Álex Arenas et al. · Liver International · 2020 · 25 citations · Full text

Medicine, Hematology, Internal Medicine +16